Company Description
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.
It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts.
It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand.
The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts.
It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
| Country | United States |
| Founded | 2005 |
| Industry | Conglomerates |
| Sector | Industrials |
| Employees | 67 |
| CEO | Ram Mukunda |
Contact Details
Address: 10224 Falls Road Potomac, Maryland 20854 United States | |
| Phone | 301-983-0998 |
| Website | igcinc.us |
Stock Details
| Ticker Symbol | IGC |
| Exchange | NYSEAMERICAN |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001326205 |
| CUSIP Number | 45408X308 |
| ISIN Number | US45408X3089 |
| Employer ID | 20-2760393 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ram Mukunda | President, Chief Executive Officer and Director |
| Claudia Grimaldi | Vice President, Principal Financial Officer, Chief Compliance Officer and Non-Independent Director |
| Rohit Goel | Senior Director of Accounting and Principal Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 24, 2024 | 10-K | Annual Report |
| May 21, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| May 2, 2024 | EFFECT | Notice of Effectiveness |
| Apr 19, 2024 | UPLOAD | Filing |
| Apr 18, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 5, 2024 | 8-K | Current Report |
| Mar 28, 2024 | 8-K | Current Report |
| Mar 22, 2024 | 8-K | Current Report |
| Mar 22, 2024 | 424B5 | Filing |
| Mar 15, 2024 | 144 | Filing |